This page covers clinically feasible scaling skin conditions thesis ideas for MD Dermatology candidates, including psoriasis, seborrhoeic dermatitis, dermatophytosis, pityriasis versicolor and pityriasis rosea, with emphasis on clinical profile, dermoscopy, mycology, histopathology, quality of life and early treatment outcomes that can usually be completed within one thesis period using patients, routine clinical assessment and investigations already available in a dermatology department. The emphasis is on scaling skin conditions thesis topics, erythematosquamous skin disease research topics, dermatology scaling disorders protocol and dermatology scaling disorders synopsis choices that can be converted into a focused protocol or synopsis without making the project dependent on non-routine resources.
Last reviewed and updated: September 2026 · 2026–27 admissions
Psoriasis
- Clinical and epidemiological profile of chronic plaque psoriasis and correlation of Psoriasis Area and Severity Index with Dermatology Life Quality Index: a cross-sectional analytical study.
- Dermoscopic patterns in chronic plaque psoriasis and their correlation with clinical severity: a cross-sectional analytical study.
- Dermoscopic-histopathological correlation in clinically indicated lesions of chronic plaque psoriasis: a cross-sectional study.
- Diagnostic accuracy of dermoscopy in differentiating chronic plaque psoriasis from other common erythematosquamous dermatoses using clinicopathological diagnosis as the reference standard.
- Correlation of scalp psoriasis severity with overall Psoriasis Area and Severity Index and quality of life: a cross-sectional analytical study.
- Clinical and onychoscopic patterns of nail psoriasis and their association with cutaneous disease severity: a cross-sectional analytical study.
- Comparison of clinical and dermoscopic features of scalp psoriasis and seborrheic dermatitis: a comparative cross-sectional study.
- Metabolic syndrome among patients with chronic plaque psoriasis and its association with disease severity: a cross-sectional analytical study.
- Association of body mass index and waist circumference with Psoriasis Area and Severity Index in chronic plaque psoriasis: a cross-sectional analytical study.
- Serum lipid abnormalities among patients with chronic plaque psoriasis and their relationship with clinical severity: a cross-sectional analytical study.
- Pruritus in chronic plaque psoriasis and its correlation with disease severity and Dermatology Life Quality Index: a cross-sectional analytical study.
- Comparison of early-onset and late-onset psoriasis with respect to clinical pattern, severity and metabolic comorbidities: a comparative cross-sectional study.
- Association of smoking, alcohol consumption and lifestyle factors with severity of chronic plaque psoriasis: a cross-sectional analytical study.
- Pattern of topical corticosteroid self-medication and inappropriate fixed-dose combination use among patients with psoriasis: a cross-sectional observational study.
- Clinical factors associated with extensive chronic plaque psoriasis: a case-control study.
- Frequency and clinical characteristics of palmoplantar involvement in patients with psoriasis: a cross-sectional observational study.
- Comparison of Psoriasis Area and Severity Index with body surface area assessment for grading chronic plaque psoriasis severity: a comparative cross-sectional study.
- Predictors of early reduction in Psoriasis Area and Severity Index within twelve weeks of routinely prescribed systemic therapy: a prospective observational study.
- Early adverse effects within twelve weeks of routinely prescribed systemic treatment for chronic plaque psoriasis: a prospective observational study.
- Retrospective analysis of clinical patterns, precipitating factors and treatment practices in patients with psoriasis at a tertiary dermatology centre.
Seborrheic Dermatitis
- Clinical and epidemiological profile of seborrheic dermatitis and its association with Dermatology Life Quality Index: a cross-sectional analytical study.
- Dermoscopic patterns of scalp seborrheic dermatitis and their correlation with clinical severity: a cross-sectional analytical study.
- Comparison of dermoscopic features of scalp seborrheic dermatitis and scalp psoriasis: a comparative cross-sectional study.
- Diagnostic accuracy of dermoscopy in differentiating scalp seborrheic dermatitis from scalp psoriasis using clinical diagnosis as the reference standard.
- Clinical patterns of facial seborrheic dermatitis and their association with scalp involvement: a cross-sectional analytical study.
- Association of scalp scaling severity with pruritus and Dermatology Life Quality Index in seborrheic dermatitis: a cross-sectional analytical study.
- Comparison of seborrheic dermatitis in patients with predominantly scalp involvement and combined scalp-facial involvement: a comparative cross-sectional study.
- Frequency and distribution of retroauricular, eyebrow and nasolabial involvement in seborrheic dermatitis: a cross-sectional observational study.
- Clinical factors associated with moderate-to-severe seborrheic dermatitis: a case-control study.
- Association of oily scalp and self-reported sebum-related factors with severity of seborrheic dermatitis: a cross-sectional analytical study.
- Relationship of seasonal variation and sweating with exacerbations of seborrheic dermatitis: a cross-sectional analytical study.
- Association of hair-care practices and cosmetic product use with severity of scalp seborrheic dermatitis: a cross-sectional analytical study.
- Pattern of topical corticosteroid self-medication among patients with facial seborrheic dermatitis: a cross-sectional observational study.
- Comparison of quality-of-life impairment in mild and moderate-to-severe seborrheic dermatitis: a comparative cross-sectional study.
- Clinical and dermoscopic characteristics of seborrheic dermatitis involving the external ear and retroauricular region: a cross-sectional study.
- Correlation of clinical erythema and scaling severity with dermoscopic vascular and scaling patterns in seborrheic dermatitis: a cross-sectional analytical study.
- Clinical profile of seborrheic dermatitis in adolescents and adults: a comparative cross-sectional study.
- Predictors of early clinical response within four weeks of routinely prescribed topical antifungal therapy for seborrheic dermatitis: a prospective observational study.
- Comparison of early clinical response to established topical treatment regimens used in routine practice for seborrheic dermatitis: a prospective observational study.
- Retrospective analysis of clinical presentation, treatment practices and short-term outcomes of seborrheic dermatitis in a tertiary dermatology clinic.
Dermatophytosis
- Clinical and epidemiological profile of dermatophytosis and correlation of disease extent with Dermatology Life Quality Index: a cross-sectional analytical study.
- Clinico-mycological correlation in patients with tinea corporis and tinea cruris using potassium hydroxide mount and fungal culture: a cross-sectional analytical study.
- Diagnostic accuracy of potassium hydroxide mount for dermatophytosis using fungal culture as the reference standard.
- Comparison of clinical features of potassium hydroxide-positive and potassium hydroxide-negative suspected dermatophytosis: a comparative cross-sectional study.
- Dermoscopic patterns of tinea corporis and their correlation with potassium hydroxide positivity: a cross-sectional analytical study.
- Diagnostic utility of dermoscopy in differentiating tinea corporis from common non-infectious erythematosquamous dermatoses using mycological examination as the reference standard.
- Clinical and mycological profile of recalcitrant dermatophytosis: a cross-sectional observational study.
- Comparison of steroid-modified and non-steroid-modified dermatophytosis with respect to clinical morphology, extent and mycological positivity: a comparative cross-sectional study.
- Pattern of topical corticosteroid and fixed-dose combination misuse among patients with dermatophytosis: a cross-sectional observational study.
- Association of topical corticosteroid misuse with atypical morphology and extensive involvement in dermatophytosis: a cross-sectional analytical study.
- Clinical and mycological characteristics of facial dermatophytosis: a cross-sectional observational study.
- Comparison of tinea faciei and non-facial tinea corporis with respect to clinical morphology and dermoscopic findings: a comparative cross-sectional study.
- Association of household clustering and sharing of fomites with extensive dermatophytosis: a cross-sectional analytical study.
- Relationship of sweating, occlusive clothing and hygiene practices with severity of tinea corporis and tinea cruris: a cross-sectional analytical study.
- Clinical factors associated with extensive dermatophytosis: a case-control study.
- Correlation of duration of dermatophytosis with clinical extent, morphology and quality-of-life impairment: a cross-sectional analytical study.
- Comparison of potassium hydroxide mount positivity between newly diagnosed and previously treated dermatophytosis: a comparative cross-sectional study.
- Predictors of mycological cure at four weeks among patients receiving routinely prescribed antifungal treatment for dermatophytosis: a prospective observational study.
- Comparison of four-week clinical and mycological response among established antifungal regimens used in routine dermatology practice: a prospective observational study.
- Retrospective analysis of patterns, prior treatment and therapeutic practices in dermatophytosis at a tertiary dermatology centre.
Pityriasis Versicolor
- Clinical and epidemiological profile of pityriasis versicolor and its association with quality-of-life impairment: a cross-sectional analytical study.
- Clinico-mycological correlation in pityriasis versicolor using potassium hydroxide mount as the routine reference standard: a cross-sectional study.
- Diagnostic accuracy of Wood's lamp examination in pityriasis versicolor using potassium hydroxide mount as the reference standard.
- Dermoscopic features of pityriasis versicolor and their correlation with potassium hydroxide positivity: a cross-sectional analytical study.
- Diagnostic accuracy of dermoscopy for suspected pityriasis versicolor using potassium hydroxide mount as the reference standard.
- Comparison of clinical, Wood's lamp and dermoscopic findings in hypopigmented and hyperpigmented pityriasis versicolor: a comparative cross-sectional study.
- Distribution patterns of pityriasis versicolor and their relationship with age, sweating and clothing habits: a cross-sectional analytical study.
- Comparison of extensive and localised pityriasis versicolor with respect to demographic and clinical risk factors: a comparative cross-sectional study.
- Association of excessive sweating with extent and severity of pityriasis versicolor: a cross-sectional analytical study.
- Relationship of oily skin and scalp seborrhea with pityriasis versicolor: a cross-sectional analytical study.
- Clinical and dermoscopic characteristics of facial pityriasis versicolor: a cross-sectional observational study.
- Comparison of pityriasis versicolor in adolescents and adults with respect to morphology, distribution and potassium hydroxide positivity: a comparative cross-sectional study.
- Frequency and clinical characteristics of pruritus in pityriasis versicolor: a cross-sectional observational study.
- Quality-of-life impairment in pityriasis versicolor and its association with visible-site involvement: a cross-sectional analytical study.
- Clinical factors associated with extensive pityriasis versicolor: a case-control study.
- Agreement between Wood's lamp examination, dermoscopy and potassium hydroxide mount in diagnosing pityriasis versicolor: a comparative diagnostic study.
- Pattern of self-medication and inappropriate topical corticosteroid use among patients with suspected pityriasis versicolor: a cross-sectional observational study.
- Predictors of mycological cure at four weeks following routinely prescribed antifungal treatment for pityriasis versicolor: a prospective observational study.
- Comparison of early clinical and mycological response to established topical antifungal regimens used in routine care for pityriasis versicolor: a prospective observational study.
- Retrospective analysis of clinical patterns, seasonal distribution and treatment practices in pityriasis versicolor at a tertiary dermatology centre.
Pityriasis Rosea
- Clinical and epidemiological profile of pityriasis rosea in patients attending a dermatology outpatient department: a cross-sectional observational study.
- Morphological variants of pityriasis rosea and their association with age, distribution and symptom severity: a cross-sectional analytical study.
- Dermoscopic features of classical pityriasis rosea and their correlation with clinical morphology: a cross-sectional study.
- Dermoscopic-histopathological correlation in clinically indicated atypical lesions of pityriasis rosea: a cross-sectional analytical study.
- Diagnostic accuracy of dermoscopy in differentiating pityriasis rosea from common erythematosquamous dermatoses using clinicopathological diagnosis as the reference standard.
- Comparison of clinical and dermoscopic features of pityriasis rosea and guttate psoriasis: a comparative cross-sectional study.
- Comparison of pityriasis rosea and secondary syphilis with respect to clinical and dermoscopic features among patients undergoing clinically indicated syphilis testing: a comparative cross-sectional study.
- Frequency and clinical significance of herald patch in pityriasis rosea: a cross-sectional analytical study.
- Pruritus in pityriasis rosea and its correlation with extent of lesions and Dermatology Life Quality Index: a cross-sectional analytical study.
- Quality-of-life impairment in pityriasis rosea and its association with visible-site and extensive involvement: a cross-sectional analytical study.
- Clinical characteristics of inverse pityriasis rosea and comparison with classical pityriasis rosea: a comparative cross-sectional study.
- Clinical profile of papular pityriasis rosea and its relationship with age and distribution: a cross-sectional observational study.
- Comparison of facial and non-facial pityriasis rosea with respect to clinical morphology and quality-of-life impairment: a comparative cross-sectional study.
- Clinical factors associated with extensive pityriasis rosea: a case-control study.
- Association of preceding upper respiratory symptoms and medication exposure with clinical pattern of pityriasis rosea: a cross-sectional analytical study.
- Relationship between duration at presentation and morphology of lesions in pityriasis rosea: a cross-sectional analytical study.
- Comparison of clinical diagnosis and routine histopathological findings in atypical pityriasis rosea where biopsy is clinically indicated: a cross-sectional study.
- Predictors of early clinical improvement within four weeks in patients receiving routine symptomatic treatment for pityriasis rosea: a prospective observational study.
- Short-term evolution of pruritus and scaling within four weeks of presentation in pityriasis rosea: a prospective observational study.
- Retrospective analysis of clinical variants, seasonal patterns and treatment practices in pityriasis rosea at a tertiary dermatology centre.
Not the dermatology subspeciality you need? Scaling skin conditions is one section of our full dermatology collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.
Browse all Dermatology Thesis Topics →
📌 Updated for 2026–2027 MD Dermatology Scaling Skin Conditions admissions
The proposed designs were reviewed for feasibility across common erythematosquamous dermatoses, with particular attention to dermoscopy, mycological confirmation, Wood's lamp examination, histopathology, steroid-modified disease and short-term outcomes.
- Most topics can be completed with clinical examination, dermoscopy, potassium hydroxide mount, fungal culture when clinically indicated, Wood's lamp examination and routine histopathology.
- Advanced molecular testing, specialised fungal typing and repeated research-only biopsy are generally not required for a feasible residency project.
- Publication potential is strongest when the diagnostic reference standard, prior-treatment status and primary severity or cure outcome are fixed before enrolment.
Generate a protocol from any topic above
Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:
- Introduction / Synopsis
- Research Question
- Aim of the Study
- Primary Objective
- Secondary Objectives
- Materials and Methods
- Inclusion Criteria
- Exclusion Criteria
- Sample Size Calculation
- Methodology
- Statistical Analysis
- Ethical Considerations
- Review of Literature
- References
- Gantt Chart / Study Timeline
- Patient Information Sheet
- Consent Form
- Data Collection Form
Already have your thesis title?
Generate the full scaling skin conditions protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.
Generate your protocol
Alongside scaling skin conditions protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.
Enquire on WhatsApp →
Scaling skin conditions research outside India
The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the scaling skin conditions research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Board and residency programmes — country by country
Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the scaling skin conditions research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.
United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a scaling skin conditions research protocol for their programme and submit it for institutional review board approval before any data are collected.
Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A scaling skin conditions IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.
Bahrain — NHRA. Trainees turning scaling skin conditions research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.
Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the scaling skin conditions research proposal is the document assessed at the start of it.
Kuwait — KIMS. A scaling skin conditions study protocol goes to the institutional committee for approval before the project begins.
Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the scaling skin conditions proposal follows the same structure throughout.
Postgraduate degrees — Malaysia, the Gulf and beyond
Malaysia — MMed, the National Medical Research Register and MREC. A scaling skin conditions dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.
PhD and Master's candidates elsewhere. University programmes generally require a full scaling skin conditions research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.
PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.
Enquire about a scaling skin conditions PhD or MMed proposal →
🔥 Trending research areas in Scaling Skin Conditions for 2026–27
- Dermoscopy of erythematosquamous disorders is increasingly useful for difficult differentials such as scalp psoriasis versus seborrhoeic dermatitis and tinea versus inflammatory plaques.
- Steroid-modified dermatophytosis remains a high-yield research area because inappropriate fixed-dose combinations can alter morphology, disease extent and mycological findings.
- Clinical versus mycological response is important in fungal disease because visible improvement does not necessarily equal confirmed mycological cure.
- Short-term evolution of pityriasis rosea and seborrhoeic dermatitis is useful for residency research because clinically meaningful symptom and scaling changes can be captured within a practical follow-up period.
Protocol and synopsis guidance
What a scaling skin conditions protocol must contain
A scaling dermatoses protocol should define the exact disease or differential diagnosis being studied rather than treating all erythematosquamous eruptions as one group. Psoriasis, seborrhoeic dermatitis, dermatophytosis, pityriasis versicolor and pityriasis rosea differ in aetiology, diagnostic confirmation and outcome measurement.
Diagnostic framework: State the role of clinical examination, dermoscopy, potassium hydroxide mount, fungal culture, Wood's lamp examination and histopathology. For infectious scaling dermatoses, microbiological confirmation is often central; for inflammatory disorders, clinicopathological correlation may be more appropriate.
Severity measurement: Disease extent, scaling, erythema, pruritus and Dermatology Life Quality Index are related but distinct outcomes. The protocol should name one primary measure and define the assessor, anatomical site and time-point.
Prior treatment: Topical corticosteroids and antifungals can alter morphology, KOH positivity and dermoscopic appearance. Previously treated and steroid-modified lesions should therefore be identified explicitly rather than analysed as though they were untreated disease.
Scaling skin conditions synopsis versus scaling skin conditions protocol
The synopsis gives the academic committee the research question, rationale, objectives, design, broad methods, sample size, statistical approach and ethics in concise form. It should show that the proposed project can be completed with the available case-load and diagnostic facilities.
The full protocol must specify the criteria that distinguish common scaling dermatoses, the selected lesion for examination, dermoscopic settings, mycological sampling technique, Wood's lamp procedure, biopsy indications and the exact reference standard for diagnostic studies.
For treatment-response research, the protocol should also define prior therapy, adherence, mycological cure where relevant and the follow-up window. Without these details, apparent clinical improvement may reflect changing morphology rather than confirmed disease clearance.
Sample size and statistical analysis
Sample size should be based on the primary objective. Profile studies need an expected proportion and precision; comparative studies need an anticipated between-group difference; diagnostic studies need assumptions about sensitivity, specificity or disease prevalence; and prospective response studies need an expected change in the predefined outcome.
Correlation between dermoscopic findings and clinical severity does not establish diagnostic accuracy. Agreement between diagnostic methods requires agreement statistics, whereas sensitivity and specificity require an independent reference standard. KOH, fungal culture, histopathology and clinical diagnosis should not be treated as equivalent reference methods without justification.
Repeated clinical, pruritus or mycological assessments require paired or longitudinal analysis. Multivariable models should remain realistic for the available sample and account for clinically important factors such as prior treatment, topical corticosteroid misuse, disease duration, extent and site when relevant.
Frequently Asked Questions – Scaling Skin Conditions Thesis Topics (2026–27)
1. How should I choose a feasible scaling skin conditions thesis topic for 2026–2027 MD Dermatology admissions?
Choose one clearly defined erythematosquamous condition or a focused differential diagnosis that matches the department's case-load and routine facilities. Feasible studies commonly use clinical examination, dermoscopy, potassium hydroxide mount, fungal culture when clinically indicated, Wood's lamp examination, routine histopathology and short-term follow-up. A strong thesis should have one primary outcome and should avoid depending on expensive biomarkers or non-routine investigations.
2. Which study designs are suitable for scaling skin conditions research?
Cross-sectional observational and analytical studies are suitable for clinical profile, severity, dermoscopic findings, quality of life and risk factors. Comparative cross-sectional designs are useful for common differentials such as scalp psoriasis versus seborrhoeic dermatitis or pityriasis rosea versus guttate psoriasis. Diagnostic accuracy studies are suitable when an appropriate independent reference standard exists. Prospective observational studies can assess early clinical or mycological response during routine treatment.
3. What should I settle with my guide before finalising a scaling skin conditions protocol?
Define the exact disease, diagnostic criteria, primary outcome, reference standard, lesion site and investigation pathway before recruitment. The protocol should state whether diagnosis rests on clinical examination, dermoscopy, potassium hydroxide mount, fungal culture, Wood's lamp examination, histopathology or a predefined combination. It should also define how prior topical corticosteroid use and previously treated lesions will be handled.
4. How should I handle clinically overlapping scaling dermatoses in a thesis?
Do not pool clinically similar disorders unless the comparison itself is the research question. Psoriasis, seborrhoeic dermatitis, dermatophytosis, pityriasis versicolor and pityriasis rosea require different confirmatory approaches. The protocol should define the distinguishing criteria in advance and specify what happens when clinical, dermoscopic and laboratory findings disagree.
5. What is the difference between a scaling skin conditions synopsis and protocol?
The synopsis is the concise academic submission containing the research question, rationale, objectives, design, sample size, broad methods, statistical plan and ethics. The full protocol is the operational document and should specify lesion selection, dermoscopic acquisition, mycological sampling, Wood's lamp examination, biopsy indications, treatment exposure, follow-up windows and analysis rules in enough detail for another investigator to reproduce the study.
6. What ethical issues should a scaling skin conditions thesis address?
For children, guardian consent and child assent from about seven years should be addressed according to institutional policy. Record-based work may seek a waiver of consent where permitted. No additional biopsy, blood sampling or microbiological procedure should be added solely for research unless specifically justified and approved, and any research-only venepuncture should state a blood volume limit. Separate consent should cover identifiable clinical photographs or video. The protocol should also define escalation pathways for extensive infection, treatment toxicity, suspected secondary syphilis, severe psoriasis or another clinically important unexpected diagnosis.
7. What is the sharpest methodological problem in scaling skin conditions research?
The sharpest problem is using an inadequate or circular reference standard in clinically overlapping erythematosquamous disorders. Dermoscopy cannot be validated against a clinical diagnosis built from the same visual features without risking circularity, and microbiological confirmation should be used where appropriate for fungal disease. If only atypical or severe lesions undergo biopsy or culture, diagnostic accuracy estimates may be biased. The protocol should therefore define the reference standard and verification pathway before enrolment.
8. Can a scaling skin conditions topic be adapted for PhD, Saudi Board, Arab Board or Gulf research requirements?
Yes. An MD synopsis usually addresses a focused clinical question that can be completed during residency, whereas a PhD research proposal generally requires a broader conceptual framework, deeper methodological justification and a larger programme of work. Board pathways may also require a separate research project, including SCFHS and Saudi Board requirements, the Arab Board of Health Specializations, and research components linked to DHP, DHA, DOH and MOHAP training programmes. The core dermatology question can often be retained, but governance, sample size, diagnostics and expected outputs should be adapted to the relevant institution or board.
9. When should I register my scaling skin conditions thesis study?
Registration and institutional approvals should be completed before prospective recruitment or study-specific data collection begins. The final protocol, diagnostic criteria, reference standard, investigation pathway, treatment exposure and statistical plan should be settled first so that the registered study matches the work actually performed. Retrospective projects should clarify ethics approval and access to clinical, mycological and pathology records before extraction.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.
Generate your protocol
